Xaira Therapeutics

Xaira Therapeutics is a biotech startup focused on leveraging artificial intelligence to transform drug discovery and development. The company develops generative AI models to design protein and antibody therapeutics, aiming to create medicines against historically hard-to-drug molecular targets. Additionally, Xaira is building foundation models for biology and disease to support target elucidation and patient stratification. The organization integrates AI, computational biology, and large-scale experimental data across the discovery and development continuum to identify novel therapies and improve success in drug development.

Operating across the San Francisco Bay Area, Seattle, and London, the company advances an oncology portfolio from discovery into early clinical development. Its work combines computational design with experimental protein engineering to guide therapeutic programs. Xaira applies analytics and model-derived insights to clinical development strategy, trial design, patient selection, and evidence generation, while building internal functions and operational models to transition its discovery programs into the clinic.